Market open · Delayed intraday data · 1:08 PM ET
Last update: Nov 9, 2026, 1:02 PM ET

Stock Analysis

Fair Isaac (FICO) Crashes ~26% as FHFA Moves to Equalize VantageScore Mortgage Pricing

Fair Isaac fell about 26.5% to $617.87 on September 29 — its steepest single-day decline in decades — after FHFA Director Bill Pulte said, in a post late the prior evening, that Fannie Mae and Freddie Mac will move to a single mortgage pricing grid that treats loans scored with Classic FICO and rival VantageScore 4.0 equally, removing the 20-point adjustment that had kept FICO the default. The move strikes FICO's most profitable franchise: its Scores segment runs ~90% operating margins, and the company had just doubled its wholesale mortgage royalty to about $10.00 per score for 2026, while VantageScore 4.0's mortgage score is $0.99 (TransUnion committed through 2028) — so lenders now face a rival score that is roughly ten times cheaper and, once the change takes effect, priced identically by the GSEs. The repricing landed predominantly on FICO: the two publicly traded bureaus that jointly own VantageScore, Equifax and TransUnion, fell materially less — about 3% — and the S&P 500 was flat. Volume ran about seven times normal, and the stock is now down roughly 69% from its 52-week high. Analyst targets are splitting between a stale ~$1,435 consensus and fresh, event-aware resets — Huber Research downgraded to Underweight at $710, while Goldman cut to $1,322 but kept a Buy — capturing how uncertain the migration path is. After the drop FICO trades near 12 times forward earnings, but the multiple now hinges on how fast lenders actually switch.

By Roberto LiccardoPublished (ET)9 min readFICO
An abstract visualization of a sharply declining stock chart over a fracturing shield and mortgage-and-credit-score motifs in deep blue and red tones, representing Fair Isaac's crash as regulators put a rival credit score on equal footing.

Why FICO stock crashed — the mortgage moat cracked

On Tuesday, September 29, 2026, Fair Isaac (NYSE: FICO) closed at $617.87, down $223.02, or about 26.5%, from an $840.89 prior close — its steepest single-day decline in decades and a fresh 52-week low [1]. The catalyst had landed the evening before: in a post late Monday, September 28, Federal Housing Finance Agency (FHFA) Director Bill Pulte said Fannie Mae and Freddie Mac — which together back roughly 70% of the U.S. mortgage market — will move to a single mortgage pricing grid that treats loans scored with Classic FICO and its rival VantageScore 4.0 equally [2]. With one post, the government-sponsored enterprises' longstanding preference for FICO — the structural advantage behind FICO's pricing power in mortgages — was set to be erased, even though no effective date or replacement pricing matrix had yet been published.

To see why the reaction was this violent, it helps to separate this week's news from what changed earlier. In early September, the FHFA had directed the GSEs to make VantageScore 4.0 available to all lenders — Fannie Mae formally announced broad availability on September 9 — but the two scores still sat on separate pricing grids, with VantageScore carrying a 20-point downward adjustment that kept FICO the default. That earlier step barely dented the stock; analysts argued FICO would retain nearly all of its share because switching still carried a pricing penalty [2]. Pulte's Monday-evening post removed that last protection: it scrapped the 20-point adjustment and put both scores on one grid, calling separate grids something that "makes zero sense" [2]. The door had been opened weeks earlier; the pricing wall behind it was now coming down, and the stock repriced in the next session.

The economics the market repriced

What makes this a genuine threat, not a headline, is FICO's own pricing history. Fair Isaac had roughly doubled its wholesale mortgage royalty to about $10.00 per score for 2026, up from $4.95 — a move aggressive enough to draw a Senate oversight inquiry earlier this year [2]. VantageScore 4.0's mortgage-origination score, meanwhile, is priced at $0.99 — a level TransUnion has committed to hold through December 2028 [2]. Lenders now face a competitor score that is roughly ten times cheaper and, once the change takes effect, priced identically by the GSEs. FICO's Scores segment is the crown jewel — it carries operating margins around 90% — and mortgage originations are its most lucrative, fastest-growing slice [2]. The market's message on Tuesday was blunt: the pricing power that drove FICO's ~24% revenue growth is now contestable in exactly the product where it mattered most.

Two-panel chart titled 'Fair Isaac (FICO): a mortgage-moat repricing, concentrated on FICO.' The left panel shows September 29 stock moves: Fair Isaac down about 26.5%, Equifax down about 3.4%, TransUnion down about 2.9%, and the S&P 500 down about 0.2% — the two credit bureaus that jointly own the rival VantageScore fell far less than FICO, a small fraction of its collapse. The right panel shows FICO's share price: a fresh 52-week low of about $595, a close of about $618, and a 52-week high of about $1,998 — the stock down roughly 69% from that high. A stat strip shows the roughly 26.5% one-day drop, volume about 7 times the 20-day average, a $13 billion market value, a trailing price-to-earnings ratio near 18, and the $10.00-versus-$0.99 per-score price gap versus VantageScore.
FICO fell about 26.5% on the FHFA's single-grid decision, while the two publicly traded bureaus that jointly own VantageScore fell materially less — about 3% — and the S&P 500 was flat, a repricing of mortgage pricing power that landed predominantly on FICO rather than a broad-market selloff (September 29, 2026 closing changes). Sources: StockAnalysis; FHFA; market data, Sep 2026.

A stock that had already been falling

Monday's crash did not come out of a clear sky. FICO had already dropped from a 52-week high near $1,998 to the $840 area as the VantageScore threat built through the year; the $617.87 close leaves it down roughly 69% from that high and far below both its ~$1,063 50-day and ~$1,236 200-day moving averages [1]. Conviction behind the move was heavy: volume ran to about 4.9 million shares, roughly seven times the ~674,000-share 20-day average [1]. After the drop the stock trades near 18 times trailing earnings and about 12 times forward estimates — optically cheap for a business with 85% gross margins and roughly $1 billion of free cash flow, but the multiple now hinges on an unknowable: how fast lenders actually migrate away from a score they have used for decades [3].

Why it matters

The same-day tape suggests this was predominantly a FICO-specific repricing rather than a broad-market selloff. VantageScore is jointly owned by the three credit bureaus, two of which are publicly traded — and while Equifax fell about 3.4% and TransUnion about 2.9%, those declines were a small fraction of FICO's collapse, and the S&P 500 was essentially flat [5]. The bureaus did fall materially, so this was not purely idiosyncratic; but if anything, wider VantageScore adoption is a potential positive for the bureaus that own it, and their moves likely reflect broad uncertainty about how a mortgage-pricing overhaul ripples through credit-data economics rather than a shared loss. The gap between FICO's −26.5% and the bureaus' ~3% is the clearest evidence that Tuesday's event fell overwhelmingly on FICO — a largely idiosyncratic, structural shock to one company's pricing power rather than a broad sector move.

The move, in one cross-section

The September 29 closes show the move fell overwhelmingly on Fair Isaac [5]:

Name (ticker)Sept 29, 2026Read-through
FICO — Fair Isaac≈−26.5%The GSEs will price FICO and VantageScore 4.0 equally — its mortgage moat repriced [1][2]
EFX — Equifax≈−3.4%Co-owns VantageScore; fell materially but a fraction of FICO's move [5]
TRU — TransUnion≈−2.9%Co-owns VantageScore; likewise a much smaller decline [5]
SPY — SPDR S&P 500 ETF≈−0.2%The market was essentially flat [5]

FICO down 26.5% while the VantageScore-owning bureaus fell about 3% and the market was flat points to a repricing that landed overwhelmingly on FICO's pricing power, even as the bureaus declined too [5].

What the Street thinks

Analyst targets are bifurcating between stale pre-crash numbers and fresh, event-aware resets — a reader should weight the recent ones. The headline consensus still reads Buy with an average target near $1,435, but that figure is largely a pre-event artifact more than double the current price and will compress as estimates are cut [6]. The most telling reaction on September 29 came from Craig Huber of Huber Research, who downgraded FICO to Underweight (from Overweight) with a $710 target — the first target set explicitly around the new pricing reality [6]. Others trimmed but held their bullish stance: Goldman Sachs's George Tong reiterated a Buy while cutting his target from $1,548 to $1,322, and Jefferies's Surinder Thind reiterated a Buy at $1,675 the same day, betting that switching inertia protects FICO's revenue [6]. That spread — a fresh downgrade to Underweight at $710 against reiterated Buys above $1,300 — captures exactly how uncertain the migration path is.

What to watch

  • An effective date and the final grid. Pulte's announcement did not specify when the single grid takes effect; the timeline and mechanics will shape how fast lenders can switch [2].
  • Lender migration. Whether large originators actually adopt the ~$0.99 VantageScore now that the GSE pricing penalty is gone, or default to FICO out of operational inertia [2].
  • FICO's fiscal-year results. Fair Isaac's fiscal year ends September 30; management's commentary on mortgage-royalty exposure and pricing at the results it typically reports in early November will be pivotal [3].
  • Estimate and target revisions. How far the stale ~$1,435 consensus falls toward event-aware levels as analysts model the royalty risk. Moves are tracked on the FICO stock page [1].

Illustrative valuation sensitivity

The scenarios below are anchored to FICO's post-crash forward earnings power (about 12× the forward estimate) and to the emerging, event-aware target range — from Huber Research's fresh $710 Underweight to reiterated Buys above $1,300 [6] — and turn on how quickly lenders migrate to the far cheaper VantageScore now that the GSE pricing penalty is gone. They are a descriptive, author-weighted exercise — not a forecast, target, recommendation, or intrinsic fair-value calculation — with subjective weights that sum to 100%.

ScenarioIllustrative priceWeightKey drivers
Upside~$78030%Switching inertia proves powerful, near-term mortgage royalties hold, the non-mortgage Scores and Software businesses keep growing, and the stock recovers toward the low end of event-aware targets [6].
Middle~$64040%Mortgage-royalty erosion is real but gradual and partly offset by the rest of the business; the stock stabilizes near the post-crash level as the market waits for hard migration data [3].
Downside~$48030%Lenders move quickly to the ~10×-cheaper VantageScore, mortgage royalties compress sharply, and both estimates and the multiple come down [2].

Weighting those (0.30 × $780 + 0.40 × $640 + 0.30 × $480) gives an author-weighted reference value near $634 — a figure mechanically derived from the scenarios and weights above, not a price target or fair-value estimate — just above Tuesday's $617.87 close and far below the stale ~$1,435 consensus target [1][6], reflecting a franchise whose mortgage pricing power is now contestable, with an unusually wide range around how fast that erosion plays out. This is a Street-target-and-earnings-based scenario exercise and descriptive analysis of a news move, not investment advice.

FICO data snapshot — September 29, 2026

FigureValueAs-of / source
Closing quote$617.87 (−$223.02, −26.52%) — a settled close; after-hours $611.27 (−1.07%)Tue, Sep 29, 2026, 4:00pm ET — StockAnalysis [1]
Prior close / open / range$840.89 prior close; opened $668.08; day range $595.19–$685.00 (a fresh 52-week low)Sep 29, 2026 [1]
Volume vs average≈4.91M shares vs a ≈674K 20-day average — roughly 7× normalSep 29 — StockAnalysis [1]
52-week range / trend$595.19–$1,998.01; down ~69% from the ~$1,998 high (−59% over 52 weeks); far below its ~$1,063 50-day and ~$1,236 200-dayAs of Sep 29 [1]
Market cap≈$13.34B (≈21.6M shares); beta ≈1.32Sep 29 — StockAnalysis [3]
ValuationAt $617.87: trailing P/E ≈17.9× (EPS ttm $34.47); forward P/E ≈12.4×; price-to-sales ≈5.6×Sep 29 — StockAnalysis [3]
Financials (TTM)Revenue ≈$2.39B (+24.1%); net income ≈$815M; gross margin ≈85%; operating margin ≈52%; free cash flow ≈$996MTTM — StockAnalysis [3]
CatalystFHFA Director Bill Pulte said Fannie Mae and Freddie Mac will use a single mortgage pricing grid treating Classic FICO and VantageScore 4.0 equally, removing VantageScore's 20-point penalty (announced; no effective date or replacement grid published yet). VantageScore 4.0's mortgage-origination score is $0.99 (TransUnion committed to hold it through Dec 2028) versus FICO's ~$10.00 wholesale mortgage royalty for 2026Posted late Mon Sep 28; −26.5% reaction Tue Sep 29 — FHFA / press [2]
Same-day peersEFX −3.4%, TRU −2.9% (both co-own VantageScore), SPY −0.2% — a repricing that landed predominantly on FICO, though the bureaus fell tooSep 29 close [5]
Analyst viewStale consensus Buy, avg target ~$1,435 (>2× the price, pre-crash); fresh Sep 29 actions: Huber Research Underweight $710 (downgrade from Overweight), Goldman Buy $1,322 (cut from $1,548), Jefferies Buy $1,675 (reiterated). RBC's Outperform/$1,525 is a standing target dating from July 30Sep 29, 2026 — StockAnalysis / analyst notes [6]

Fair Isaac (FICO) stock FAQ

Why did FICO stock crash on September 29, 2026?

Fair Isaac fell about 26.5% to $617.87 — its steepest single-day decline in decades — after FHFA Director Bill Pulte announced, in a post late the prior evening (Monday, September 28), that Fannie Mae and Freddie Mac will move to a single mortgage pricing grid that treats loans scored with Classic FICO and rival VantageScore 4.0 equally. Previously, VantageScore 4.0 carried a 20-point downward adjustment that kept FICO the default score for loans sold to the government-sponsored enterprises; removing it, and putting both scores on one grid, erased the structural advantage behind FICO's mortgage-score pricing power. The market read it as a permanent change to FICO's most profitable business, and the stock repriced accordingly on roughly seven times its normal volume.

What exactly did the FHFA change?

FHFA Director Bill Pulte said Fannie Mae and Freddie Mac will use a single loan-level pricing grid for mortgages regardless of whether they were scored with Classic FICO or VantageScore 4.0, calling the prior system of separate grids something that 'makes zero sense.' The key mechanical change is the removal of a 20-point downward adjustment that had been applied to VantageScore 4.0 scores — so the two models are now priced identically by the GSEs. This built on an earlier step in early September, when the FHFA directed the GSEs to make VantageScore 4.0 available to all lenders (Fannie Mae announced broad availability on September 9); that move drew a muted reaction because the separate pricing grids still favored FICO. The unified-grid announcement, posted late Monday, September 28, removed that last protection, though Pulte did not specify an effective date or publish a replacement pricing matrix.

How big is the mortgage business to FICO?

It is central to FICO's profitability. FICO's Scores segment — the credit-score royalty business — carries operating margins around 90%, and mortgage originations are its most lucrative and fastest-growing slice. The company had roughly doubled its wholesale mortgage royalty to about $10.00 per score for 2026, up from $4.95, a hike aggressive enough to draw a Senate oversight inquiry. VantageScore, by contrast, will hold its mortgage-score price at $0.99 through December 2028. That combination — a rival roughly ten times cheaper that the GSEs now price identically — is why the market treated the FHFA's decision as a direct threat to the pricing power that drove FICO's roughly 24% revenue growth.

Did other credit-score or bureau stocks fall too?

They fell far less than FICO, which is the key tell. VantageScore is jointly owned by the three big credit bureaus, and the two publicly traded ones dropped only modestly: Equifax was down about 3.4% and TransUnion about 2.9% on September 29, while the S&P 500 was essentially flat. Wider VantageScore adoption is arguably a potential positive for the bureaus that own it, so their declines likely reflect broad uncertainty about how a mortgage-pricing overhaul ripples through credit-data economics rather than a shared loss. The bureaus did fall materially, so the day was not purely idiosyncratic — but the gap between FICO's roughly 26.5% drop and the bureaus' roughly 3% is the clearest sign that the repricing fell overwhelmingly on FICO's pricing power rather than being a broad sector-wide selloff.

Is FICO stock cheap after the crash?

On the multiple it looks inexpensive, but the multiple is the wrong anchor here. After the drop FICO trades near 18 times trailing earnings and about 12 times forward estimates, for a business with roughly 85% gross margins and about $1 billion of free cash flow. The problem is that forward estimates were set before the pricing change and will likely be cut; the real question is how much mortgage-royalty revenue FICO loses and how quickly. If switching inertia protects near-term royalties, the shares are cheap; if lenders migrate quickly to the far cheaper VantageScore now that the GSE pricing penalty is gone, both estimates and the multiple can fall further. That uncertainty, not the current ratio, is what the stock is pricing.

What do analysts think of FICO now?

Their targets are splitting between stale pre-crash numbers and fresh, event-aware resets, and the recent ones matter more. The headline consensus still reads Buy with an average target near $1,435, but that figure predates the decision and sits at more than double the current price, so it will compress. The most telling September 29 action came from Craig Huber of Huber Research, who downgraded FICO to Underweight (from Overweight) with a $710 target — the first set explicitly around the new pricing reality. Others trimmed but stayed bullish: Goldman Sachs's George Tong reiterated a Buy while cutting his target from $1,548 to $1,322, and Jefferies's Surinder Thind reiterated a Buy at $1,675 the same day, betting switching inertia protects FICO's revenue (RBC Capital's Ashish Sabadra kept an Outperform, though its $1,525 target predates the event). That spread captures how wide the range of outcomes is.

View all research →
An abstract visualization of a falling stock chart over a search and AI motif in orange-red tones, representing Reddit's crash after a Q3 revenue beat was overshadowed by a Google AI search-traffic warning.
Stock AnalysisOctober 30, 2026 · 12 min read

Reddit (RDDT) Crashes ~30% After a Q3 Beat on a Google AI Search-Traffic Warning

Reddit crashed about 30% to roughly $90.79 on October 30 — a striking reaction, because the quarter itself was strong: revenue of $895 million rose 53% year over year, a clear beat, with net income of $283 million, diluted EPS of $1.40 and adjusted EBITDA of $402 million. The stock cratered on what management said about the future. On the earnings call, CEO Steve Huffman warned that search referrals fell more than a million per week on average in October as Google answers more queries with AI, and that daily active users (around 130 million) could fall a low-double-digit percentage in the fourth quarter if the trend held. Investors also fixed on a 2% year-over-year decline in US daily actives — Reddit's most valuable market, where revenue per user is more than five times the international level — and on fourth-quarter revenue guidance of $1.00–$1.03 billion that came in below expectations; Citizens downgraded the stock before the open. The one bullish counterweight was monetization: revenue per user still jumped 36% globally. The move was company-specific — Reddit's roughly 30% drop was about four times the moves of social peers Snap and Pinterest (each down ~7%), on a day the broad market fell about 2%. After the crash Reddit trades at roughly 14 times forward earnings with about $3 billion of net cash — not expensive for 50%-plus growth, if the growth is durable. The whole debate is whether rising revenue per user can keep outrunning a top of the funnel that AI search is draining.

An abstract visualization of a falling stock chart over an automotive and circuit-grille motif in steel-blue and red tones, representing General Motors' drop after a Q3 beat-and-raise was overshadowed by 2027 cost and EV concerns.
Stock AnalysisOctober 20, 2026 · 10 min read

General Motors (GM) Falls ~8% Despite a Q3 Beat and a $20B Buyback

General Motors fell about 8% to roughly $75.77 on October 20 — a striking reaction, because GM beat on third-quarter earnings, raised its full-year profit outlook and announced a $20 billion buyback. Adjusted earnings of $3.70 a share topped estimates on revenue of about $50 billion, and GM lifted the midpoint of its full-year adjusted-EPS guidance to about $13.25 (from $13.00) and raised its free-cash-flow outlook. The stock fell anyway on what the guidance implied, not the quarter. The full-year outlook implies a softer fourth quarter — only about $2.7 billion of operating profit versus $4.1 billion in the third, as a Silverado/Sierra redesign temporarily cuts truck deliveries by roughly 35,000 units — the raised $13.25 EPS midpoint still landed just below the roughly $13.41 the Street expected, and management flagged about $2 billion of 2026 cost inflation plus a conditional scenario of more in 2027. Two things that look like culprits mostly were not: the 62% drop in EV sales was already known and reflects a distorted 2025 comparison, and tariff costs are now expected near the low end of an existing range. Crucially, GM did not cut its 2027 outlook — it still expects next year to improve if conditions hold. The move was clearly company-specific — Ford fell only about 1%, Stellantis was flat and the S&P 500 rose — so this was a repricing of GM's forward earnings, not an auto-sector sell-off. The valuation captures the tension: GM trades at barely five to six times the forward earnings it guides to, extraordinarily cheap, because the market prices automakers for the downturn, not the peak. A $20 billion buyback into that multiple is powerfully accretive if earnings hold — but whether they hold in 2027 is exactly the question. Analysts keep a Buy consensus and an average target near $104.

An abstract visualization of a rising stock chart over a molecular antibody and DNA-helix motif in cool teal and violet tones, representing Summit Therapeutics' jump on a new ivonescimab kidney-cancer trial.
Stock AnalysisOctober 19, 2026 · 10 min read

Summit Therapeutics (SMMT) Jumps ~6% on a New Ivonescimab Kidney-Cancer Trial

Summit Therapeutics rose about 6% to roughly $15.57 on October 19 after announcing it had opened a global Phase II trial of ivonescimab — its closely watched lead drug — in previously untreated advanced clear cell kidney cancer, with partner Akeso. The key nuance: this is the opening of a mid-stage study, not a data readout, so it is an incremental catalyst that expands the story rather than one that proves it. Summit is effectively a one-drug company: ivonescimab is a PD-1/VEGF bispecific antibody, licensed from China's Akeso, that outperformed Merck's Keytruda in a Chinese lung-cancer trial — nearly doubling progression-free survival and, in updated data, delivering a significant overall-survival benefit (30.8 vs 22.6 months) — though the global trial behind its U.S. filing has yet to formally confirm that survival benefit in Western patients. With no product revenue and a market value above $12 billion, essentially all of Summit's worth is the market's bet on that drug, so a new indication is a fresh call option on the thesis. Two bigger items frame it: AstraZeneca agreed in late September to invest about $2 billion in Summit equity (a ~12% stake), transforming the balance sheet and removing the financing overhang, and the FDA has a November 14, 2026 decision date on ivonescimab in EGFR-mutated lung cancer — a near-term, binary catalyst that matters far more than a trial start. Monday's move was partly company-specific and partly a tailwind: biotech broadly rallied, with the sector ETF up about 2.5%, but Summit outperformed. The risks are a binary valuation on one molecule, an unconfirmed Western survival benefit, and a stock down roughly 47% from its high. Analysts carry a Buy consensus and an average target near $30, inside a wide range from about $12 to the mid-$40s.